Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Respironics, Inc.

http://www.respironics.com

Latest From Respironics, Inc.

Recalls And Multiple Market Challenges Test Philips’ Resilience Into Q1

Philips’ revenues contraction in the first quarter of 2022 was less than feared and its order book remains impressive, but challenges presented by the recall program and generic post-COVID factors for the year ahead remain substantial.

Commercial Sales & Earnings

Philips CEO Finds Comfort In Solid Product Demand As Triple Headwind Blows In

Frans van Houten has promised a summer update on Royal Philips’ medium-term outlook after the company was hit from all sides in late 2021. He expects the resulting headwinds to persist into early 2022.

Recalls Medical Device

Finance Watch: One Small Pain Drug Maker And Three Biotech SPACs Launch IPOs

After a brief lull in US initial public offerings, PainReform and three special purpose acquisition companies kicked off September’s IPOs. Also, Immunovant offering grossed $173.9m, Carlyle Group bought 5% stake in China’s Salubris and Erasca increased its series B to $236m. 

Financing Growth

Post-Pandemic World: Former VA Secretary Predicts Acceleration In Telemedicine, Digitalization, Hospital Redesign

Former VA Secretary David Shulkin said health care post-COVID-19 requires a makeover with greater hospital integration and ongoing telemedicine to address behavioral and physical issues.

Coronavirus COVID-19 Digital Health
See All

Company Information

  • Other Names / Subsidiaries
    • Philips
UsernamePublicRestriction

Register